OTCBB:MCET

Multicell Technologies Stock Signals

etoro logo Buy MCET
*Your capital is at risk
$0.000001
+0 (+0%)
At Close: Jun 23, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for MultiCell Technologies, Inc.

General

Signal Type Signal Value Data
Score 0.000 23 days ( 0 %
Last Price $0.000001 0 %
Performance History
7 Days
$0.000001 $0.000001
0%
30 Days
$0.000001 $0.000001
0%
12 Mos
$0.000001 $0.000001
0%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 5.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.000001 - $0.000001
Trend - 3 mos -54.12 % High Width: 259.46 %
Pred. range - 3 mos N/A - $0.00000092782701 Low -100.00 % - -7.22 %
Volume Direction Sell High Volume: 27 · Direction: 0
Pivot Short Buy Very Low May 18, 2026 - 25 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low May 15, 2026 - 26 days
Long MA 3 mos Sell Medium May 15, 2026 - 26 days
Short/Long MA 3 mos Sell Medium May 26, 2026 - 20 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.4
Signal Type Signal Value Importance Data
Trend - 12 mos -18.94 % Very High Width: 563.72 %
Pred. range - 12 mos N/A - $0.00007060806538 High -100.00 % - 6,960.81 %
Short MA 12 mos Sell Very High May 15, 2026 - 26 days
Long MA 12 mos Buy Very High Oct 30, 2025 - 159 days
Short/Long MA 12 mos Sell Very High Nov 21, 2025 - 143 days
Pivot Long Buy Low May 18, 2026 - 25 days
RSI Long Pivot Signal Sell Low Jan 13, 2026 - 109 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT MULTICELL TECHNOLOGIES, INC.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therape...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
EAT
$140.46
16.94% Jun 05
E
ETD
$20.67
4.79% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE